Author Correction: Caring for patients with cancer in the COVID-19 era.

Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
07 2020
Historique:
pubmed: 5 6 2020
medline: 5 6 2020
entrez: 5 6 2020
Statut: ppublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41591-020-0948-7 PMID: 32494062 PMC: PMC7269160
pubmed: 32494062
doi: 10.1038/s41591-020-0948-7
pii: 10.1038/s41591-020-0948-7
pmc: PMC7269160
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

1146

Subventions

Organisme : Department of Health
ID : NIHR300024
Pays : United Kingdom

Commentaires et corrections

Type : ErratumFor

Auteurs

Joris van de Haar (J)

Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Louisa R Hoes (LR)

Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Charlotte E Coles (CE)

Cancer Research UK Cambridge Cancer Center, Cambridge, UK.

Kenneth Seamon (K)

Cancer Research UK Cambridge Cancer Center, Cambridge, UK.

Stefan Fröhling (S)

German Cancer Consortium, Heidelberg, Germany.
Division of Translational Medical Oncology, National Center for Tumor Diseases Heidelberg and German Cancer Research Center, Heidelberg, Germany.

Dirk Jäger (D)

Department of Medical Oncology, National Center for Tumor Diseases Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.

Franco Valenza (F)

Università Statale di Milano, Milan, Italy.
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Filippo de Braud (F)

Università Statale di Milano, Milan, Italy.
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Luigi De Petris (L)

Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.

Jonas Bergh (J)

Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.

Ingemar Ernberg (I)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.

Benjamin Besse (B)

Gustave Roussy Cancer Campus, Villejuif, France.

Fabrice Barlesi (F)

Gustave Roussy Cancer Campus, Villejuif, France.
Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.

Elena Garralda (E)

Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.

Alejandro Piris-Giménez (A)

Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.

Michael Baumann (M)

German Cancer Consortium, Heidelberg, Germany.
German Cancer Research Center, Heidelberg, Germany.

Giovanni Apolone (G)

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Jean Charles Soria (JC)

Gustave Roussy Cancer Campus, Villejuif, France.

Josep Tabernero (J)

Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
ORCID: 0000-0002-2495-8139

Carlos Caldas (C)

Cancer Research UK Cambridge Cancer Center, Cambridge, UK. carlos.caldas@cruk.cam.ac.uk.
Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Center, University of Cambridge, Cambridge, UK. carlos.caldas@cruk.cam.ac.uk.
ORCID: 0000-0003-3547-1489

Emile E Voest (EE)

Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. e.voest@nki.nl.
Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands. e.voest@nki.nl.
ORCID: 0000-0001-8249-9586

Classifications MeSH